Organizing Committee Members - Immuno Oncology 2019
Wassil Nowicky
Founder
Nowicky Pharma
Austria
Wassil Nowicky(Biography)
Wassil Nowicky is the Director of Nowicky Pharma and President of the Ukrainian Anti-Cancer Institute (Vienna, Austria). He has finished his study at the Radiotechnical Faculty of the Technical University of Lviv (Ukraine) by the end of 1955 from graduation to Diplomingeniueur in 1960 whose title was nostrificated in Austria in 1975. He is the Author of over 300 scientific articles dedicated to cancer research. He is a real member of the New York Academy of Sciences, member of the European Union for Applied Immunology and of the American Association for scientific progress, Honorary Doctor of the Janka Kupala University in Hrodno, doctor honoris causa of the Open international university on Complex Medicine in Colombo, Honorary Member of the Austrian Society of a name od Albert Schweizer. He has received the award for merits of National guild of pharmacists of America. the award of Austrian Society of sanitary, hygiene and publichealth services and others.
Wassil Nowicky(Research Area)
Oncology, Cancer, Immuno Oncology.
M G Hanna
Founder
Vaccinogen, Inc.
USA
M G Hanna (Biography)
Dr. Michael G. Hanna, Jr., Ph.D., founded Vaccinogen, Inc. in 2007 and served as its Chairman and Chief Executive Officer until August 2014. Dr. Hanna served as the Chief Scientific Officer of Vaccinogen, Inc., and served as its Chief Executive Officer until October 1st 2010. He served as the Chief Scientific Officer of Intracel Holdings Corporation. He served as the Chairman of the Board, Chief Executive Officer and President of PerImmune, Inc. He served as President of Intracel Holdings Corporation. From 1985 to 1994, he was the Chief Operating Officer of Organon Teknika/Biotechnology Research Institute. He founded the Litton Institute of Applied Biotechnology (LIAB), which Organon Teknika acquired in 1985 and was a Senior Vice President at Organon Teknika. Dr. Hanna served as the Chairman of Intracel Holdings Corporation. Dr. Hanna served as Chairman Emeritus at Vaccinogen, Inc. since August 2014 at Vaccinogen, Inc. and also served as its Director and Member of Medical Advisory Board until September 29, 2017. He served as a Director of the National Cancer Institute From 1975 to 1983, Frederick Cancer Research Center.
M G Hanna (Research Area)
Cancer, Immunology.